U.S. markets open in 8 hours 47 minutes
  • S&P Futures

    3,614.75
    -21.75 (-0.60%)
     
  • Dow Futures

    29,660.00
    -214.00 (-0.72%)
     
  • Nasdaq Futures

    12,223.75
    -33.75 (-0.28%)
     
  • Russell 2000 Futures

    1,837.40
    -15.60 (-0.84%)
     
  • Crude Oil

    44.88
    -0.65 (-1.43%)
     
  • Gold

    1,771.90
    -16.20 (-0.91%)
     
  • Silver

    22.09
    -0.54 (-2.40%)
     
  • EUR/USD

    1.1975
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    0.8420
    -0.8780 (-100.00%)
     
  • Vix

    20.84
    -0.41 (-1.93%)
     
  • GBP/USD

    1.3341
    +0.0027 (+0.20%)
     
  • USD/JPY

    103.8530
    -0.2320 (-0.22%)
     
  • BTC-USD

    18,524.92
    -7.96 (-0.04%)
     
  • CMC Crypto 200

    365.32
    +27.82 (+8.24%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,435.25
    -209.46 (-0.79%)
     

Collegium to Host Conference Call to Discuss Fourth Quarter and Full-Year 2019 Financial Results and Provide Corporate Update

STOUGHTON, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, confirmed today the details of the year-end earnings call, previously announced on February 13, 2020. The company will host a conference call and live audio webcast on Thursday, February 27, 2020 at 4:30 p.m. Eastern Time. The company will discuss its financial results for the Fourth Quarter and Full-Year 2019 and provide a corporate update.

Conference Call Information:

To access the conference call, please dial (888) 698-6931 (U.S.) or (805) 905-2993 (International) and refer to Conference ID: 829-8360. An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts.

Contact:
Alex Dasalla
adasalla@collegiumpharma.com